GAMMA Investing’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$63.8K Sell
4,702
-916
-16% -$14.7K ﹤0.01% 2206
2026
Q2
$115K Sell
5,618
-1
-0% -$23 ﹤0.01% 1703
2026
Q1
$124K Buy
5,619
+1,586
+39% +$27.6K 0.01% 1504
2025
Q4
$47.5K Buy
4,033
+446
+12% +$5.73K ﹤0.01% 2105
2025
Q3
$56.8K Buy
3,587
+412
+13% +$5.98K ﹤0.01% 1899
2025
Q2
$36.4K Buy
3,175
+1,799
+131% +$20.3K ﹤0.01% 2122
2025
Q1
$18.6K Sell
1,376
-156
-10% -$2.59K ﹤0.01% 2423
2024
Q4
$25.9K Buy
1,532
+765
+100% +$14.9K ﹤0.01% 2128
2024
Q3
$15.6K Buy
767
+67
+10% +$1.37K ﹤0.01% 2252
2024
Q2
$15.8K Sell
700
-105
-13% -$2.75K ﹤0.01% 2007
2024
Q1
$21.1K Buy
805
+527
+190% +$15K ﹤0.01% 1617
2023
Q4
$8.39K Buy
+278
New +$7.54K ﹤0.01% 2001

Other funds holding CC

GAMMA Investing's CC Position: Q3 2026 in Review

GAMMA Investing reduced its Chemours (CC) stake by 16% in Q3 2026, selling an estimated $14.7K and leaving 4,702 shares worth $63.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2206.

GAMMA Investing first reported a position in CC in Q4 2023 and has held it in 12 quarters since. The position peaked at $124K in Q1 2026. 17 funds tracked by Wall St. Rank hold CC as of Q3 2026.

  • GAMMA Investing held 4,702 shares of Chemours worth $63.8K as of Q3 2026.
  • GAMMA Investing sold 916 Chemours shares in Q3 2026, an estimated $14.7K.
  • Chemours made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2206 holding.
  • GAMMA Investing first reported a position in Chemours in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Chemours position peaked at $124K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Chemours as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.